Epidemiological considerations following long-term surveillance of invasive group A streptococcal disease in The Netherlands, 1992-2003

Clinical Microbiology and Infection

Volumn 11, Issue 7, 2005, Pages 564-568

  Vlaminckx, B J M ^a   van Pelt, W ^b   Schellekens, J F P ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Group A streptococci; Invasive infections; Streptococcus pyogenes; Surveillance; The Netherlands; Toxic shock like syndrome

Indexed keywords

ADULT; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; FATALITY; FEMALE; HEALTH SURVEY; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGY; NETHERLANDS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; TOXIC SHOCK SYNDROME;

STREPTOCOCCUS PYOGENES; STREPTOCOCCUS SP. 'GROUP A';

EID: 21244474391     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2005.01179.x     Document Type: Article

References (22)

1. Davies HD, McGeer A, Schwartz B et al. Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. N Engl J Med 1996; 335: 547-554.
2. Kiska DL, Thiede B, Caracciolo J et al. Invasive group A streptococcal infections in North Carolina: epidemiology, clinical features, and genetic and serotype analysis of causative organisms. J Infect Dis 1997; 176: 992-1000.
3. Sharkawy A, Low DE, Saginur R et al. Severe group A streptococcal soft-tissue infections in Ontario: 1992-1996. Clin Infect Dis 2002; 34: 454-460.
4. O'Brien KL, Beall B, Barrett NL et al. Epidemiology of invasive group A streptococcus disease in the United States, 1995-1999. Clin Infect Dis 2002; 35: 268-276.
5. Svensson N, Oberg S, Henriques B et al. Invasive group A streptococcal infections in Sweden in 1994 and 1995: epidemiology and clinical spectrum. Scand J Infect Dis 2000; 32: 609-614.
6. Moses AE, Goldberg S, Korenman Z, Ravins M, Hanski E, Shapiro M. Invasive group A streptococcal infections, Israel. Emerg Infect Dis 2002; 8: 421-426.
7. The Working Group on Severe Streptococcal Infections. Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. JAMA 1993; 269: 390-391.
8. Colman G, Tanna A, Efstratiou A, Gaworzewska ET. The serotypes of Streptococcus pyogenes present in Britain during 1980-1990 and their association with disease. J Med Microbiol 1993; 39: 165-178.
9. Stromberg A, Romanus V, Burman LG. Outbreak of group A streptococcal bacteremia in Sweden: an epidemiologic and clinical study. J Infect Dis 1991; 164: 595-598.
10. Schwartz B, Facklam RR, Breiman RF. Changing epidemiology of group A streptococcal infection in the USA. Lancet 1990; 336: 1167-1171.
11. Johnson DR, Stevens DL, Kaplan EL. Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis. J Infect Dis 1992; 166: 374-382.
12. Tyrrell GJ, Lovgren M, Forwick B, Hoe NP, Musser JM, Talbot JA. M types of group A streptococcal isolates, submitted to the National Centre for Streptococcus (Canada) from 1993 to 1999. J Clin Microbiol 2002; 40: 4466-4471.
13. Kriz P, Motlova J. Analysis of active surveillance and passive notification of streptococcal diseases in the Czech Republic. Adv Exp Med Biol 1997; 418: 217-219.
14. Schellekens JF, Schouls LM, van Pelt W, Esveld M, van Leeuwen WJ. Group A streptococci: a change in virulence? Neth J Med 1998; 52: 209-217.
15. Schellekens JF, Schools LM, van Silfhout A et al. The resurgence of group A streptococcal disease. Nederlands Tijdschrift Med Microbiol 1995; 4: 78-83.
16. Mascini EM, Jansze M, Schellekens JF et al. Invasive group A streptococcal disease in the Netherlands: evidence for a protective role of anti-exotoxin A antibodies. J Infect Dis 2000; 181: 631-638.
17. Vlaminckx B, Van Pelt W, Schouls L et al. Epidemiological features of invasive and noninvasive group A streptococcal disease in the Netherlands, 1992-1996. Eur J Clin Microbiol Infect Dis 2004; 23: 434-444.
18. Kaufhold A, Podbielski A, Baumgarten G, Blokpoel M, Top J, Schouls L. Rapid typing of group A streptococci by the use of DNA amplification and non-radioactive allele-specific oligonucleotide probes. FEMS Microbiol Lett 1994; 119: 19-25.
19. Vlaminckx B, Van Pelt W, Schouls L et al. Long-term surveillance of invasive group A streptococcal disease in The Netherlands, 1994-2003. Clin Microbiol Infect 2005; 11: 226-231.
20. Health Protection Agency. Pyogenic and non-pyogenic streptococcal bacteraemias, England, Wales, and Northern Ireland: 2003. Commun Dis Rep Weekly 2004; 14 [serial online].
21. Abudu L, Blair I, Fraise A, Cheng KK. Methicillin-resistant Staphylococcus aureus (MRSA): a community-based prevalence survey. Epidemiol Infect 2001; 126: 351-356.
22. Schwartz RE, Lowe DA, Stayer SA, Pasquariello CA, Schlichting CM. Bacterial endocarditis prophylaxis: what is recommended and what is practiced? J Clin Anesth 1994; 6: 5-9.